The First Fully AI-Generated Drug Enters Clinical Trials in Human Patients
“The first drug fully generated by artificial intelligence entered clinical trials with human patients this week,” reports CNBC: Insilico Medicine, a Hong Kong-based biotech startup with more than $400 million in funding, created the drug, INS018_055, as a treatment for idiopathic pulmonary fibrosis, a chronic disease that causes scarring in Read more…






